Business1 month ago
Corcept Therapeutics Stock Plummets 50% After FDA Request for More Data
Corcept Therapeutics (NASDAQ: CORT) saw its stock price drop approximately 50% on December 31, 2023, following a request from the U.S. Food and Drug Administration (FDA)...